Hanmi Science (008930) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hanmi Science (008930) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.96 Billion ≈ $5.39 Million USD) by net assets (₩1.00 Trillion ≈ $677.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 008930 market cap for the company's overall valuation and market capitalisation.
Hanmi Science - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Hanmi Science's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hanmi Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hanmi Science ranked by their cash flow conversion efficiency. Explore Hanmi Science cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Solaria Energía y Medio Ambiente S.A
MC:SLR
|
0.068x |
|
Valiant Holding AG
SW:VATN
|
0.005x |
|
REN - Redes Energéticas Nacionais SGPS S.A
LS:RENE
|
-0.084x |
|
Pharma Reaserch Prod Co Ltd
KQ:214450
|
0.085x |
|
Cohu Inc
NASDAQ:COHU
|
0.013x |
|
Ebos Group Ltd
AU:EBO
|
0.017x |
|
Jyoti CNC Automation Limited
NSE:JYOTICNC
|
0.007x |
|
Angang Steel Co Ltd Class A
SHE:000898
|
0.036x |
Annual Cash Flow Conversion Efficiency for Hanmi Science (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hanmi Science from 2000 to 2025. View 008930 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩959.19 Billion ≈ $650.03 Million |
₩47.66 Billion ≈ $32.30 Million |
0.050x | -49.79% |
| 2024-12-31 | ₩838.70 Billion ≈ $568.38 Million |
₩82.99 Billion ≈ $56.24 Million |
0.099x | +121.62% |
| 2023-12-31 | ₩787.47 Billion ≈ $533.66 Million |
₩35.16 Billion ≈ $23.83 Million |
0.045x | +242.35% |
| 2022-12-31 | ₩724.75 Billion ≈ $491.15 Million |
₩9.45 Billion ≈ $6.41 Million |
0.013x | -34.24% |
| 2021-12-31 | ₩690.29 Billion ≈ $467.80 Million |
₩13.69 Billion ≈ $9.28 Million |
0.020x | -5.45% |
| 2020-12-31 | ₩658.73 Billion ≈ $446.41 Million |
₩13.82 Billion ≈ $9.36 Million |
0.021x | +3.99% |
| 2019-12-31 | ₩645.69 Billion ≈ $437.57 Million |
₩13.02 Billion ≈ $8.83 Million |
0.020x | +387.66% |
| 2018-12-31 | ₩653.09 Billion ≈ $442.59 Million |
₩2.70 Billion ≈ $1.83 Million |
0.004x | +108.17% |
| 2017-12-31 | ₩665.15 Billion ≈ $450.76 Million |
₩-33.68 Billion ≈ $-22.83 Million |
-0.051x | -142.85% |
| 2016-12-31 | ₩647.56 Billion ≈ $438.84 Million |
₩76.52 Billion ≈ $51.86 Million |
0.118x | +47.12% |
| 2015-12-31 | ₩584.25 Billion ≈ $395.94 Million |
₩46.93 Billion ≈ $31.80 Million |
0.080x | +539.61% |
| 2014-12-31 | ₩417.71 Billion ≈ $283.08 Million |
₩5.25 Billion ≈ $3.55 Million |
0.013x | +2287.90% |
| 2013-12-31 | ₩409.07 Billion ≈ $277.22 Million |
₩-234.79 Million ≈ $-159.11K |
-0.001x | -100.95% |
| 2010-12-31 | ₩604.83 Billion ≈ $409.88 Million |
₩36.49 Billion ≈ $24.73 Million |
0.060x | -55.95% |
| 2009-12-31 | ₩444.88 Billion ≈ $301.49 Million |
₩60.93 Billion ≈ $41.29 Million |
0.137x | +31.54% |
| 2008-12-31 | ₩393.00 Billion ≈ $266.33 Million |
₩40.92 Billion ≈ $27.73 Million |
0.104x | -48.66% |
| 2006-12-31 | ₩291.16 Billion ≈ $197.32 Million |
₩59.05 Billion ≈ $40.02 Million |
0.203x | -4.83% |
| 2005-12-31 | ₩219.66 Billion ≈ $148.86 Million |
₩46.81 Billion ≈ $31.72 Million |
0.213x | +53.31% |
| 2004-12-31 | ₩181.81 Billion ≈ $123.21 Million |
₩25.27 Billion ≈ $17.13 Million |
0.139x | -4.75% |
| 2003-12-31 | ₩155.62 Billion ≈ $105.46 Million |
₩22.71 Billion ≈ $15.39 Million |
0.146x | -34.08% |
| 2002-12-31 | ₩146.43 Billion ≈ $99.23 Million |
₩32.42 Billion ≈ $21.97 Million |
0.221x | -22.75% |
| 2001-12-31 | ₩131.69 Billion ≈ $89.25 Million |
₩37.74 Billion ≈ $25.58 Million |
0.287x | +39.40% |
| 2000-12-31 | ₩90.93 Billion ≈ $61.62 Million |
₩18.69 Billion ≈ $12.67 Million |
0.206x | -- |
About Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more